Plutux
XBIEquity

State Street SPDR S&P Biotech ETF

$168.23

 

52-week range

Twelve months

Assets under management
$12.0B
Expense ratio
0.35%
Holdings
155
NAV
$168.23
Inception
Jan 31, 2006
Issuer
SPDR
Asset class
Equity
Exchange
Average volume
8.8M
Volume
50-day average
200-day average
Day range
Previous close
Domicile
US
Official page
ssga.com

About this fund

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

Sector exposure

  • Healthcare99.60%
  • Financial Services0.40%

Top holdings

Largest positions by weight. Each links to its own stock page.

Similar funds

All ETFs

Questions

What does XBI hold?

XBI is State Street SPDR S&P Biotech ETF, run by SPDR and listed in the US. It currently holds 155 positions; the largest are MRNA, TWST, APGE.

What is the expense ratio of XBI?

XBI charges 0.35% per year. The fee is taken out of the fund's assets, so it shows up as a small drag on performance rather than as a separate bill.

How large is XBI?

The fund manages $12.0B. Size matters mainly for liquidity: larger funds tend to trade with tighter spreads and are less likely to be closed by the issuer.

How do I research what is inside XBI?

The holdings list on this page links every position to its own Plutux stock page, where you get the company's price history, financials and AI analysis.

Market data is provided for information only and is not investment advice. Figures can be delayed or restated by the data provider.

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026